Table 4.
Gene | Evidence for causality |
Familial Cancer Syndrome Evidence | Evidence from next generation sequencing studies |
|||
---|---|---|---|---|---|---|
Cancer syndrome | Gastric cancer related syndrome? |
Mutated? | Recurrently mutated? |
Gastric cancer related pathway? |
||
Tier 1 | ||||||
CDH1 | Strong | HDGC | Yes | NA | NA | CDH1 |
PALB2 | Strong | Breast/ Pancreas cancer | No | Yes25,28,36,42 | Yes | HRDR |
Tier 2 | ||||||
CTNNA1 | Moderate | HDGC | Yes | Yes 36 | Yes | CDH1 |
MSH2 | Moderate | LS | Yes | Yes 31,42 | Yes | No |
TP53 | Moderate | LFS | Yes | Yes 31 | No | No |
STK11 | Moderate | PJS | Yes | Yes 36 | Yes | No |
ATM | Moderate | Breast cancer | No | Yes 25,31,36 | Yes | HRDR |
BRCA1 | Moderate | HBOC | Yes | Yes 25,28 | Yes | HRDR |
BRCA2 | Moderate | HBOC | Yes | Yes 25,31,36 | Yes | HRDR |
BRIP1 | Moderate | Breast cancer | No | Yes 25,31 | Yes | HRDR |
ATR | Moderate | None | No | Yes 31,42 | HRDR | |
Tier 3 | ||||||
APC | Moderate/low | FAPS | Yes | No | No | No |
SMAD4 | Moderate/low | JPS | Yes | No | No | No |
BMPR1A | Moderate/low | JPS | Yes | No | No | No |
ENG | Moderate/low | JPS | Yes | No | No | No |
MSR1 | Moderate/low | Oeasophageal | No | Yes 42 | Yes | No |
SDHB | Moderate/low | Paraganglioma- Pheochromocytoma |
No | Yes 36 | No | SDHA/B |
SDHA | Moderate/low | Paraganglioma- Pheochromocytoma |
No | Yes 25 | No | SDHA/B |
RAD51C | Moderate/low | Breast cancer | No | Yes 28 | No | HRDR |
NBN | Moderate/low | Ovarian cancer | No | Yes 42 | No | HRDR |
RECQL5 | Moderate/low | Breast cancer | No | Yes 42 | No | HRDR |
FANCC | Moderate/low | Breast cancer | No | Yes 31 | No | HRDR |